T. Zielonka

发表

Post‐treatment (not interim) positron emission tomography‐computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R‐HyperCVAD

A. Goy, A. Mato, A. Pecora, 2012, Cancer.

Early Detection of Deep Venous Thrombosis in Trauma Patients

G. Simonian, S. Cohn, D. O'Connor, 2020, Cureus.

Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia

Xiao-Jie Yan, N. Chiorazzi, V. Thodima, 2014, Leukemia & lymphoma.

Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma

A. Goy, A. Mato, A. Pecora, 2013, Leukemia & lymphoma.

Dose Intensive Induction Followed By Allogeneic Stem Cell Transplantation More Than Doubles Progression-Free and Overall Survival In “Double-Hit” Lymphoma (DHL)

D. Vesole, A. Goy, A. Mato, 2013 .

Marijuana Legalization and Rates of Crashing Under the Influence of Tetrahydrocannabinol and Alcohol.

M. Schreiber, S. Cohn, Natasha Keric, 2021, The American surgeon.

A CT-Derived Measurement of Sarcopenia Fails to Predict Falls.

S. Cohn, David H Parr, Manisha Parulekar, 2022, The American surgeon.

Umbilical Fascial Defects are Common and Predict Trocar Site Hernias After Laparoscopic Appendectomy

K. Rippey, S. Cohn, Y. Kuo, 2021, The American surgeon.

The association between the Mantle Cell Lymphoma International Prognostic Index (MIPI) and survival in patients treated with rituximab-HCVAD (RHCVAD) alternating with rituximab-methotrexate-AraC (R-MTX-AraC).

A. Goy, A. Mato, A. Pecora, 2010 .

Inferior Vena Cava Filters Lack Benefit in High-Risk Trauma Patients

S. Cohn, Y. Kuo, M. Blatt, 2022, The American surgeon.

Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients

Christopher K. Rogers, J. Sharma, T. Nyirenda, 2018, Cureus.

Post‐treatment (not interim) positron emission tomography‐computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R‐HyperCVAD

A. Goy, A. Mato, A. Pecora, 2012, Cancer.

Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).

D. Siegel, A. Goy, A. Mato, 2010 .